Literature DB >> 16773483

Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.

Matjaz Jereb1, Tadeja Kotar.   

Abstract

BACKGROUND: The value of elevated serum procalcitonin concentration for differentiating between typical and atypical community-acquired pneumonia was assessed and compared with other parameters that are usually used in clinical practice. PATIENTS AND METHODS: Thirty consecutive adult patients with community-acquired bacterial pneumonia admitted to the Department of Infectious Diseases, University Medical Center Ljubljana, Slovenia, were included in this prospective study. Only those patients for whom the etiology of bacterial pneumonia was confirmed participated in the study.
RESULTS: The median serum procalcitonin level in patients with typical pneumonia was 7.64 ng/ml (range 0.26-63.16) and in the group with atypical pneumonia 0.80 ng/ml (range 0.13-34.90). A significant difference between the typical and atypical pneumonia groups was found only for the procalcitonin serum concentration on admission. The standard laboratory markers of bacterial infections, such as C-reactive protein, total leukocyte count and immature polymorphonuclear cells, did not discriminate between typical and atypical etiology. Median procalcitonin levels were significantly higher among patients with bacteremic pneumonia.
CONCLUSIONS: Determination of the procalcitonin level may provide useful additional diagnostic information on the etiology of pneumonia and could have a crucial influence on the initial antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773483     DOI: 10.1007/s00508-006-0563-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  26 in total

1.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

2.  Measurement of procalcitonin levels in children with bacterial or viral meningitis.

Authors:  D Gendrel; J Raymond; M Assicot; F Moulin; J L Iniguez; P Lebon; C Bohuon
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

3.  Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.

Authors:  P P Gleason; T P Meehan; J M Fine; D H Galusha; M J Fine
Journal:  Arch Intern Med       Date:  1999-11-22

4.  Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.

Authors:  P Toikka; K Irjala; T Juvén; R Virkki; J Mertsola; M Leinonen; O Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2000-07       Impact factor: 2.129

5.  Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.

Authors:  A Polzin; M Pletz; R Erbes; M Raffenberg; H Mauch; S Wagner; G Arndt; H Lode
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671

6.  Procalcitonin in patients with acute myocardial infarction.

Authors:  Mojca Remskar; Matija Horvat; Sergej Hojker; Marko Noc
Journal:  Wien Klin Wochenschr       Date:  2002-03-28       Impact factor: 1.704

7.  C-reactive protein as an indicator of resolution of sepsis in the intensive care unit.

Authors:  S M Yentis; N Soni; J Sheldon
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

8.  C-reactive protein as an indicator of sepsis.

Authors:  P Póvoa; E Almeida; P Moreira; A Fernandes; R Mealha; A Aragão; H Sabino
Journal:  Intensive Care Med       Date:  1998-10       Impact factor: 17.440

9.  Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

Authors:  G Fleischhack; D Cipic; J Juettner; C Hasan; U Bode
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

10.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

View more
  11 in total

1.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

2.  Usefulness of procalcitonin for diagnosis of infective endocarditis.

Authors:  Matjaz Jereb; Tadeja Kotar; Tomaz Jurca; Tatjana Lejko Zupanc
Journal:  Intern Emerg Med       Date:  2009-04-09       Impact factor: 3.397

3.  Postoperative pain and systemic inflammatory stress response after preoperative analgesia with clonidine or levobupivacaine: a randomized controlled trial.

Authors:  Jasminka Persec; Zoran Persec; Ino Husedzinovic
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Association of Consecutive Influenza Vaccinations and Pneumonia: A Population-Based Case-Control Study.

Authors:  Liang-Tsai Yeh; Chi-Ho Chan; Shun-Fa Yang; Han-Wei Yeh; Ying-Tung Yeh; Yu-Hsun Wang; Ming-Chih Chou; Chao-Bin Yeh; Ying-Hock Teng
Journal:  Int J Environ Res Public Health       Date:  2019-03-26       Impact factor: 3.390

Review 5.  Evidence-Informed Practice: Diagnostic Questions in Urinary Tract Infections in the Elderly.

Authors:  Richard Pescatore; Joshua D Niforatos; Salim Rezaie; Anand Swaminathan
Journal:  West J Emerg Med       Date:  2019-06-11

Review 6.  Diagnosing Viral and Atypical Pathogens in the Setting of Community-Acquired Pneumonia.

Authors:  Grant W Waterer
Journal:  Clin Chest Med       Date:  2016-12-21       Impact factor: 2.878

7.  Serum amyloid a, C-reactive protein, and procalcitonin levels in children with Mycoplasma pneumoniae infection.

Authors:  Yuanyuan Jiang; Wenyang Wang; Zhijun Zhang; Xianfen Ma; Yanyan Sang; Jin Wang; Guoxiang Xu; Qiang Feng; Shuping Zhao
Journal:  J Clin Lab Anal       Date:  2022-02-11       Impact factor: 2.352

8.  [The diagnosis of sepsis].

Authors:  L Engelmann
Journal:  Intensivmed Notfallmed       Date:  2006

9.  Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis.

Authors:  Heike Schützle; Johannes Forster; Andrea Superti-Furga; Reinhard Berner
Journal:  Eur J Pediatr       Date:  2008-12-24       Impact factor: 3.183

Review 10.  New markers in pneumonia.

Authors:  Chao-Wen Cheng; Ming-Hsien Chien; Shih-Chi Su; Shun-Fa Yang
Journal:  Clin Chim Acta       Date:  2013-02-04       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.